Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2014 (2014), Article ID 135823, 14 pages
http://dx.doi.org/10.1155/2014/135823
Research Article

Listening to Those at the Frontline: Patient and Healthcare Personnel Perspectives on Tuberculosis Treatment Barriers and Facilitators in High TB Burden Regions of Argentina

1School of Nursing, Columbia University, 630 West 168 Street, New York, NY 10032, USA
2Institute for Clinical Effectiveness and Healthcare Policy, Dr. Emilio Ravignani 2024, C1414CPT Buenos Aires, Argentina
3Division of Family and Community Medicine, Hospital Italiano de Buenos Aires, Juan D. Perón 4190, C1181ACH Buenos Aires, Argentina
4School of Nursing, Loyola University, 6363 Saint Charles Avenue, Stallings Hall, New Orleans, LA 70118, USA

Received 27 May 2014; Revised 6 September 2014; Accepted 8 September 2014; Published 28 September 2014

Academic Editor: David C. Perlman

Copyright © 2014 Sarah J. Iribarren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Das and R. Horton, “Tuberculosis-time to accelerate progress,” The Lancet, vol. 375, no. 9728, pp. 1755–1757, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Enarsona and N. E. Billo, “Critical evaluation of the Global DOTS Expansion Plan,” Bulletin of the World Health Organization, vol. 85, no. 5, pp. 395–398, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. World Health Organization, An Expanded DOTS Framework for Effective Tuberculosis Control, WHO, Geneva, Switzerland, 2002.
  4. Tuberculosis Coalition for Technical Assistance, International Standards for Tuberculosis Care (ISTC). Diagnosis, Treatment, Public Health, The Hague, The Netherlands, 2nd edition, 2009.
  5. Instituto Nacional de Enfermedades Respiratorias E. Coni, Resultado del Tratamiento de los Casos de Tuberculosis, Situación Nacional y por Jurisdicción, Buenos Aires, Argentina, 2010.
  6. World Health Organization, Treatment for Tuberculosis: Guidelines, WHO/HTM/TB, 4th edition, 2009.
  7. World Health Organization, TB Country Profile Argentina, 2010, WHO, Geneva, Switzerland, 2012, http://www.who.int/tb/country/data/profiles/en/.
  8. Instituto Nacional de Enfermedades Respiratorias E. Coni, Notificación de Casos de Tuberculosis en la República Argentina. Período 1980-2012, ANLIS, 2013.
  9. Instituto Nacional de Infermidades Respiritorias E. Coni, Resultados del Tratamiento de Casos de Tuberculosis. Situación Nacional y por Jurisdicción, República Argentina, 2007, 2010.
  10. D. A. Mitchison, “How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 2, no. 1, pp. 10–15, 1998. View at Google Scholar · View at Scopus
  11. G. Maartens and R. J. Wilkinson, “Tuberculosis,” The Lancet, vol. 370, no. 9604, pp. 2030–2043, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. World Health Organization, Adherence to Long Term Therapies: Evidence for Action, World Health Organization, Geneva, Switzerland, 2003.
  13. World Health Organization, International Standards for Tuberculosis Care: Diagnosis, Treatment and Public Health, T.C.f.T. Assistance, 2006.
  14. S. A. Munro, S. A. Lewin, H. J. Smith, M. E. Engel, A. Fretheim, and J. Volmink, “Patient adherence to tuberculosis treatment: a systematic review of qualitative research,” PLoS Medicine, vol. 4, no. 7, pp. 1230–1245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Cramm, H. J. Finkenflügel, V. Møller, and A. P. Nieboer, “TB treatment initiation and adherence in a South African community influenced more by perceptions than by knowledge of tuberculosis,” BMC Public Health, vol. 10, article 72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Chirico, N. Morcillo, and A. Kuriger, “Is the DOTS strategy a useful tool to fight against Tuberculosis in a median incidence area of Buenos Aires Province?” International Journal of Tuberculosis & Lung Disease, 2005. View at Google Scholar
  17. C. Chirico, A. Kuriger, H. Fernandez, and N. Morcillo, “Evolution of tuberculosis incidence rates in the V sanitary zone of Buenos Aires province during the period 1984–1996,” Medicina, vol. 59, no. 4, pp. 332–338, 1999. View at Google Scholar · View at Scopus
  18. I. N. de Kantor, O. Latini, and L. Barrera, “Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries,” Medicina, vol. 58, no. 2, pp. 202–208, 1998. View at Google Scholar
  19. M. S. Imaz, M. D. Sequeira, A. Aguirre et al., “Bacteriological diagnosis of tuberculosis in Argentina: results of a national survey,” Cadernos de Saude Publica, vol. 23, no. 4, pp. 885–896, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. J. Palmero, M. Ambroggi, A. Brea et al., “Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina,” International Journal of Tuberculosis and Lung Disease, vol. 8, no. 6, pp. 778–784, 2004. View at Google Scholar · View at Scopus
  21. E. Zerbini, M. C. Chirico, B. Salvadores, B. Amigot, S. Estrada, and G. Algorry, “Delay in tuberculosis diagnosis and treatment in four provinces of Argentina,” International Journal of Tuberculosis and Lung Disease, vol. 12, no. 1, pp. 63–68, 2008. View at Google Scholar · View at Scopus
  22. J. W. Creswell, A. C. Klassen, V. L. Plano-Clark, and K. C. Smith, Best Practices for Mixed Method Research in the Health Sciences, NIH National Institutes of Health, Washington, DC, USA, 2011.
  23. N. K. Denzin and Y. S. Lincoln, Handbook of Qualitative Research, Sage, Thousand Oaks, Calif, USA, 2000.
  24. M. Sandelowski, “Whatever happened to qualitative description?” Research in Nursing and Health, vol. 23, no. 4, pp. 334–40, 2000. View at Google Scholar
  25. C. Chirico, A. Kuriger, M. Etchevarria, L. Casamajor, and N. Morcillo, “Anti-tuberculosis treatment evaluation in Northern districts of Buenos Aires suburbs,” Medicina, vol. 67, no. 2, pp. 131–135, 2007. View at Google Scholar · View at Scopus
  26. Y. Lincoln and E. Guba, Naturalistic Inquiry, Sage Publications, Newbury Park, Calif, USA, 1985.
  27. M. Sandelowski, “What's in a name? Qualitative description revisited,” Research in Nursing and Health, vol. 33, no. 1, pp. 77–84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Lienhardt, K. Manneh, V. Bouchier, G. Lahai, P. J. M. Milligan, and K. P. W. J. McAdam, “Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in the Gambia,” The International Journal of Tuberculosis and Lung Disease, vol. 2, no. 9, pp. 712–718, 1998. View at Google Scholar · View at Scopus
  29. C. Lienhardt and J. A. Ogden, “Tuberculosis control in resource-poor countries: have we reached the limits of the universal paradigm?” Tropical Medicine and International Health, vol. 9, no. 7, pp. 833–841, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. K. M. de Cock and R. E. Chaisson, “Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection,” International Journal of Tuberculosis and Lung Disease, vol. 3, no. 6, pp. 457–465, 1999. View at Google Scholar · View at Scopus
  31. F. Hane, S. Thiam, A. S. Fall et al., “Identifying barriers to effective tuberculosis control in Senegal: an anthropological approach,” International Journal of Tuberculosis and Lung Disease, vol. 11, no. 5, pp. 539–543, 2007. View at Google Scholar · View at Scopus
  32. J. Ogden, S. Rangan, M. Uplekar et al., “Shifting the paradigm in tuberculosis control: illustrations from India,” International Journal of Tuberculosis and Lung Disease, vol. 3, no. 10, pp. 855–861, 1999. View at Google Scholar · View at Scopus
  33. F. A. D. Kaona, M. Tuba, S. Siziya, and L. Sikaona, “An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment,” BMC Public Health, vol. 4, article 68, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Sagbakken, J. C. Frich, and G. Bjune, “Barriers and enablers in the management of tuberculosis treatment in Addis Ababa, Ethiopia: a qualitative study,” BMC Public Health, vol. 8, article 11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Xu, W. Lu, Y. Zhou, L. Zhu, H. Shen, and J. Wang, “Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study,” BMC Health Services Research, vol. 9, article 169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. K. Ray, N. Sharma, M. M. Singh, and G. K. Ingle, “Economic burden of tuberculosis in patients attending DOT centres in Delhi,” The Journal of Communicable Diseases, vol. 37, no. 2, pp. 93–98, 2005. View at Google Scholar · View at Scopus
  37. M. A. Khan, J. D. Walley, S. N. Witter, S. K. Shah, and S. Javeed, “Tuberculosis patient adherence to direct observation: results of a social study in Pakistan,” Health Policy and Planning, vol. 20, no. 6, pp. 354–365, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. K. W. Kizito, S. Dunkley, M. Kingori, and T. Reid, “Lost to follow up from tuberculosis treatment in an urban informal settlement (Kibera), Nairobi, Kenya: what are the rates and determinants?” Transactions of the Royal Society of Tropical Medicine & Hygiene, vol. 105, no. 1, pp. 52–57, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. S. P. Ntshanga, R. Rustomjee, and M. L. H. Mabaso, “Evaluation of directly observed therapy for tuberculosis in KwaZulu-Natal, South Africa,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 103, no. 6, pp. 571–574, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Sagbakken, J. C. Frich, and G. A. Bjune, “Perception and management of tuberculosis symptoms in Addis Ababa, Ethiopia,” Qualitative Health Research, vol. 18, no. 10, pp. 1356–1366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Tekle, D. H. Mariam, and A. Ali, “Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia,” International Journal of Tuberculosis and Lung Disease, vol. 6, no. 7, pp. 573–579, 2002. View at Google Scholar · View at Scopus
  42. J. Volmink, P. Matchaba, and P. Garner, “Directly observed therapy and treatment adherence,” The Lancet, vol. 355, no. 9212, pp. 1345–1350, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. J. C. M. Macq, S. Theobald, J. Dick, and M. Dembele, “An exploration of the concept of directly observed treatment (DOT) for tuberculosis patients: from a uniform to a customised approach,” International Journal of Tuberculosis and Lung Disease, vol. 7, no. 2, pp. 103–109, 2003. View at Google Scholar · View at Scopus
  44. D. S. Pope and R. E. Chaisson, “TB treatment: as simple as dot?” The International Journal of Tuberculosis and Lung Disease, vol. 7, no. 7, pp. 611–615, 2003. View at Google Scholar · View at Scopus
  45. J. K. Kangangi, D. Kibuga, J. Muli et al., “Decentralisation of tuberculosis treatment from the main hospitals to the peripheral health units and in the community within Machakos District, Kenya,” International Journal of Tuberculosis and Lung Disease, vol. 7, no. 9, supplement 1, pp. S5–S13, 2003. View at Google Scholar · View at Scopus
  46. T. E. Nyirenda, A. D. Harries, F. Gausi et al., “Decentralisation of tuberculosis services in an urban setting, Lilongwe, Malawi,” International Journal of Tuberculosis and Lung Disease, vol. 7, no. 9, supplement 1, pp. S21–S28, 2003. View at Google Scholar · View at Scopus
  47. P. C. Hill, W. Stevens, S. Hill et al., “Risk factors for defaulting from tuberculosis treatment: a prospective cohort study of 301 cases in the Gambia,” International Journal of Tuberculosis and Lung Disease, vol. 9, no. 12, pp. 1349–1354, 2005. View at Google Scholar · View at Scopus
  48. N. Martins, J. Grace, and P. M. Kelly, “An ethnographic study of barriers to and enabling factors for tuberculosis treatment adherence in Timor Leste,” International Journal of Tuberculosis and Lung Disease, vol. 12, no. 5, pp. 532–537, 2008. View at Google Scholar · View at Scopus
  49. Instituto Nacional de Enfermidades Respiratorias E. Coni, “Evaluation of tuberculosis treatment results in Argentina. National status and by jurisdiction, 2009,” 2011, http://www.anlis.gov.ar/inst/iner/archivos/TratamientoTB_2009.pdf.
  50. J. Volmink and P. Garner, “Directly observed therapy for treating tuberculosis,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD003343, 2007. View at Google Scholar · View at Scopus
  51. T. R. Frieden and J. A. Sbarbaro, “Promoting adherence to treatment for tuberculosis: the importance of direct observation,” World Hospitals and Health Services, vol. 43, no. 2, pp. 30–33, 2007. View at Google Scholar
  52. T. M. R. M. de Figueiredo, T. C. S. Villa, L. M. Scatena et al., “Performance of primary healthcare services in tuberculosis control,” Revista de Saude Publica, vol. 43, no. 5, pp. 825–831, 2009. View at Publisher · View at Google Scholar · View at Scopus